Skip to content
VuFind
  • Login
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
Advanced
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Save to List
  • Permanent link
Cover Image

Saved in:
Bibliographic Details
Main Author: Tripdatabase
Format: Recurso digital
Language:
Published: Zenodo 2025
Subjects:
risks
combined
sitagliptin
dapagliflozin
type
diabetes
patients
Online Access:https://doi.org/10.5281/zenodo.17705620
Tags: Add Tag
No Tags, Be the first to tag this record!
  • Holdings
  • Description
  • Table of Contents
  • Comments
  • Similar Items
  • Staff View

Internet

https://doi.org/10.5281/zenodo.17705620

Similar Items

  • Should dapagliflozin be discontinued before a surgical procedure?
    by: Tripdatabase
    Published: (2025)
  • Figure 1 from: Habeeb MQ, Abdulridha MK, Salman IN (2026) Metabolic effects of mangosteen supplementation as an adjuvant to sitagliptin/metformin in newly diagnosed type 2 diabetes Iraqi patients. Pharmacia 73: 1-9. https://doi.org/10.3897/pharmacia.73.e182949
    by: Habeeb, Mays Qays, et al.
    Published: (2026)
  • How effective are educational interventions by diabetic specialist nurses in improving patients' understanding of diabetes management?
    by: Tripdatabase
    Published: (2026)
  • Which part of information about diabetes complications will most affect the compliance of a 50-year-old male patient with type 2 diabetes?
    by: Tripdatabase
    Published: (2025)
  • EVALUATION OF THE EFFICACY OF SGLT2 INHIBITOR THERAPY IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION
    by: Cotoneț, Tatiana, et al.
    Published: (2025)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs